Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Panacos Attracts $18.3M Round To Fund HIV Drug Development (BioWorld Today)
News | 04. 16. 2008
Panacos Pharmaceuticals
Panacos Pharmaceuticals Inc. raised $18.3 million in its Series C round of financing.
